Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Carlos Eduardo Pires Sousa"'
Autor:
Vladmir Cláudio Cordeiro de Lima, Maria Nirvana Formiga, Elzabeth Santana Santos, Debora de Melo Gagliato, Aldo Lourenço Abbade Dettino, Ludmilla Thomé Domingos Chinen, Augusto Akikubo Rodrigues Pereira, Paulo Henrique Aires Freitas, Flavio Augusto Ismael Pinto, Adriana Regina Gonçalves Ribeiro, Victor Hugo Fonseca de Jesus, Marclesson S. Alves, Ulisses Ribaldo Nicolau, Carlos Eduardo Pires Sousa, Joyce Lisboa, José A. Rinck, Newton Augusto Ferreira Rodrigues, Marcello Ferretti Fanelli, Fernando Vidigal Padua
Publikováno v:
Journal of Clinical Oncology. 30:466-466
466 Background: Sunitinib, a multitarget tyrosine-kinase inhibitor, has become a standard of care for first-line low and intermediate risk metastatic renal cell carcinoma (mRCC). Sunitinib-induced hypothyroidism and hypertension have been correlated
Autor:
Rafael Costa Lessa, Rafael Malagoli Rocha, Vladmir Cláudio Cordeiro de Lima, Marcello Ferretti Fanelli, Alexandre Andre Balieiro Anastacio da Costa, Felipe D'Almeida Costa, Carlos Eduardo Pires Sousa, Stephania M. Bezerra, Carlos Frederico Lopes Benevides, Paulo Henrique Aires Freitas, Newton Augusto Ferreira Rodrigues, Elizabeth Santana dos Santos, Fernando Vidigal Padua, Debora de Melo Gagliato, Geraldine Eltz Lima, Augusto Akikubo Rodrigues Pereira, Flavio Augusto Ismael Pinto
Publikováno v:
Web of Science
643 Background: Factors predictive of response to anthracyclines can help selecting patients who really benefit from its use. TOP2A (a target of anthracyclines) and HER2 genes are both amplified in 40% of breast cancers. Data from literature are conf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c101f395e409ea9cd1321899ed918755
https://publons.com/wos-op/publon/17669002/
https://publons.com/wos-op/publon/17669002/